Study of the Relationship Between Serum Adiponectin and Clinical Prognosis in Patients Undergoing Cardiac Surgery
The purpose of this study is to investigate the relationship between serum adiponectin and clinical prognosis in patients undergoing cardiac surgery.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Study of the Relationship Between Serum Adiponectin and Clinical Prognosis in Patients Undergoing Cardiac Surgery|
|Study Start Date:||July 2011|
|Estimated Study Completion Date:||August 2012|
|Estimated Primary Completion Date:||July 2012 (Final data collection date for primary outcome measure)|
Adiponectin, an adipose tissue derived protein, is an abundant protein hormone regulatory of numerous metabolic processes. Since its discovery, adiponectin has garnered considerable attention for its role in cardiovascular pathology. It has been shown to be a predictor of cardiovascular events in both the general population and patients undergoing cardiac surgery. In this study,we are planning to investigate the relationship between serum adiponectin and clinical prognosis in patients undergoing cardiac surgery.
|Contact: Chunhu Gu, MDfirstname.lastname@example.org|
|Xijing Hospital||Not yet recruiting|
|Xi'an, Shannxi, China, 710032|
|Contact: Chunhu Gu, MD email@example.com|
|Principal Investigator: Chunhu Gu, MD|
|Principal Investigator: Yukun Cao, MD|
|Study Chair:||Dinghua Yi, MD||Xijing Hospital|